Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Authors:
- 1 May 2017
- journal article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 48, 53-56
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Hyponatremia following esclicarbazepine therapySeizure: European Journal of Epilepsy, 2015
- Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trialEpilepsia, 2014
- Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective studyEpilepsy Research, 2014
- ILAE Official Report: A practical clinical definition of epilepsyEpilepsia, 2014
- Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepineSeizure: European Journal of Epilepsy, 2013
- Epilepsy in the elderly: facts and challengesActa Neurologica Scandinavica, 2010
- Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsyEpilepsy Research, 2010
- Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III studyEpilepsia, 2009
- Eslicarbazepine Acetate (BIA 2-093)Neurotherapeutics, 2007
- Pharmacological and clinical aspects of antiepileptic drug use in the elderlyEpilepsy Research, 2006